nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitroglycerin—ALDH2—synovial membrane of synovial joint—psoriatic arthritis	0.0237	0.463	CbGeAlD
Nitroglycerin—GUCY1A2—tendon—psoriatic arthritis	0.00674	0.132	CbGeAlD
Nitroglycerin—Rash—Auranofin—psoriatic arthritis	0.00522	0.0055	CcSEcCtD
Nitroglycerin—Dermatitis—Auranofin—psoriatic arthritis	0.00521	0.00549	CcSEcCtD
Nitroglycerin—Anaphylactoid reaction—Triamcinolone—psoriatic arthritis	0.0051	0.00537	CcSEcCtD
Nitroglycerin—Anaphylactoid reaction—Methylprednisolone—psoriatic arthritis	0.00509	0.00536	CcSEcCtD
Nitroglycerin—Nausea—Auranofin—psoriatic arthritis	0.00491	0.00518	CcSEcCtD
Nitroglycerin—Visual disturbance—Betamethasone—psoriatic arthritis	0.00472	0.00498	CcSEcCtD
Nitroglycerin—Visual disturbance—Dexamethasone—psoriatic arthritis	0.00472	0.00498	CcSEcCtD
Nitroglycerin—ALDH2—skin of body—psoriatic arthritis	0.0047	0.092	CbGeAlD
Nitroglycerin—Anaphylactoid reaction—Betamethasone—psoriatic arthritis	0.00463	0.00488	CcSEcCtD
Nitroglycerin—Anaphylactoid reaction—Dexamethasone—psoriatic arthritis	0.00463	0.00488	CcSEcCtD
Nitroglycerin—Sweating increased—Prednisolone—psoriatic arthritis	0.00452	0.00476	CcSEcCtD
Nitroglycerin—GUCY1A3—tendon—psoriatic arthritis	0.00425	0.0831	CbGeAlD
Nitroglycerin—GUCY1B3—tendon—psoriatic arthritis	0.00421	0.0825	CbGeAlD
Nitroglycerin—Sweating increased—Triamcinolone—psoriatic arthritis	0.00415	0.00438	CcSEcCtD
Nitroglycerin—Sweating increased—Methylprednisolone—psoriatic arthritis	0.00415	0.00437	CcSEcCtD
Nitroglycerin—Coma—Methotrexate—psoriatic arthritis	0.0041	0.00432	CcSEcCtD
Nitroglycerin—NPR1—tendon—psoriatic arthritis	0.00394	0.0772	CbGeAlD
Nitroglycerin—Infestation NOS—Methylprednisolone—psoriatic arthritis	0.00379	0.004	CcSEcCtD
Nitroglycerin—Infestation—Methylprednisolone—psoriatic arthritis	0.00379	0.004	CcSEcCtD
Nitroglycerin—Bradycardia—Prednisolone—psoriatic arthritis	0.00378	0.00398	CcSEcCtD
Nitroglycerin—Sweating increased—Dexamethasone—psoriatic arthritis	0.00377	0.00397	CcSEcCtD
Nitroglycerin—Sweating increased—Betamethasone—psoriatic arthritis	0.00377	0.00397	CcSEcCtD
Nitroglycerin—Sweating—Methylprednisolone—psoriatic arthritis	0.00364	0.00383	CcSEcCtD
Nitroglycerin—ALDH2—tendon—psoriatic arthritis	0.00358	0.0701	CbGeAlD
Nitroglycerin—Visual impairment—Prednisolone—psoriatic arthritis	0.00358	0.00377	CcSEcCtD
Nitroglycerin—Renal failure acute—Methotrexate—psoriatic arthritis	0.00353	0.00372	CcSEcCtD
Nitroglycerin—Bradycardia—Triamcinolone—psoriatic arthritis	0.00348	0.00366	CcSEcCtD
Nitroglycerin—Bradycardia—Methylprednisolone—psoriatic arthritis	0.00347	0.00365	CcSEcCtD
Nitroglycerin—Dermatitis exfoliative—Methotrexate—psoriatic arthritis	0.00345	0.00364	CcSEcCtD
Nitroglycerin—Visual disturbance—Methotrexate—psoriatic arthritis	0.00344	0.00362	CcSEcCtD
Nitroglycerin—Rhinitis—Triamcinolone—psoriatic arthritis	0.00342	0.00361	CcSEcCtD
Nitroglycerin—Rhinitis—Methylprednisolone—psoriatic arthritis	0.00341	0.0036	CcSEcCtD
Nitroglycerin—Pharyngitis—Triamcinolone—psoriatic arthritis	0.00339	0.00357	CcSEcCtD
Nitroglycerin—Anaphylactoid reaction—Methotrexate—psoriatic arthritis	0.00337	0.00355	CcSEcCtD
Nitroglycerin—Arrhythmia—Prednisolone—psoriatic arthritis	0.00332	0.00349	CcSEcCtD
Nitroglycerin—Sweating increased—Prednisone—psoriatic arthritis	0.00328	0.00346	CcSEcCtD
Nitroglycerin—Visual impairment—Methylprednisolone—psoriatic arthritis	0.00328	0.00346	CcSEcCtD
Nitroglycerin—Erythema—Prednisolone—psoriatic arthritis	0.00323	0.00341	CcSEcCtD
Nitroglycerin—Cardiac disorder—Methylprednisolone—psoriatic arthritis	0.00316	0.00333	CcSEcCtD
Nitroglycerin—Bradycardia—Betamethasone—psoriatic arthritis	0.00315	0.00332	CcSEcCtD
Nitroglycerin—Bradycardia—Dexamethasone—psoriatic arthritis	0.00315	0.00332	CcSEcCtD
Nitroglycerin—Angiopathy—Methylprednisolone—psoriatic arthritis	0.00309	0.00326	CcSEcCtD
Nitroglycerin—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.00308	0.00324	CcSEcCtD
Nitroglycerin—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.00307	0.00324	CcSEcCtD
Nitroglycerin—Arrhythmia—Triamcinolone—psoriatic arthritis	0.00305	0.00321	CcSEcCtD
Nitroglycerin—Vision blurred—Prednisolone—psoriatic arthritis	0.00305	0.00321	CcSEcCtD
Nitroglycerin—Arrhythmia—Methylprednisolone—psoriatic arthritis	0.00304	0.00321	CcSEcCtD
Nitroglycerin—Visual impairment—Betamethasone—psoriatic arthritis	0.00299	0.00315	CcSEcCtD
Nitroglycerin—Visual impairment—Dexamethasone—psoriatic arthritis	0.00299	0.00315	CcSEcCtD
Nitroglycerin—Mental disorder—Methylprednisolone—psoriatic arthritis	0.00298	0.00314	CcSEcCtD
Nitroglycerin—Erythema—Triamcinolone—psoriatic arthritis	0.00297	0.00313	CcSEcCtD
Nitroglycerin—Erythema—Methylprednisolone—psoriatic arthritis	0.00297	0.00312	CcSEcCtD
Nitroglycerin—Angioedema—Prednisolone—psoriatic arthritis	0.00295	0.00311	CcSEcCtD
Nitroglycerin—Vertigo—Prednisolone—psoriatic arthritis	0.0029	0.00306	CcSEcCtD
Nitroglycerin—Syncope—Prednisolone—psoriatic arthritis	0.0029	0.00305	CcSEcCtD
Nitroglycerin—Loss of consciousness—Prednisolone—psoriatic arthritis	0.00284	0.00299	CcSEcCtD
Nitroglycerin—Angiopathy—Dexamethasone—psoriatic arthritis	0.00281	0.00296	CcSEcCtD
Nitroglycerin—Angiopathy—Betamethasone—psoriatic arthritis	0.00281	0.00296	CcSEcCtD
Nitroglycerin—Arrhythmia—Dexamethasone—psoriatic arthritis	0.00277	0.00292	CcSEcCtD
Nitroglycerin—Arrhythmia—Betamethasone—psoriatic arthritis	0.00277	0.00292	CcSEcCtD
Nitroglycerin—Bradycardia—Prednisone—psoriatic arthritis	0.00275	0.00289	CcSEcCtD
Nitroglycerin—Angioedema—Triamcinolone—psoriatic arthritis	0.00272	0.00286	CcSEcCtD
Nitroglycerin—Angioedema—Methylprednisolone—psoriatic arthritis	0.00271	0.00286	CcSEcCtD
Nitroglycerin—Erythema—Dexamethasone—psoriatic arthritis	0.0027	0.00284	CcSEcCtD
Nitroglycerin—Erythema—Betamethasone—psoriatic arthritis	0.0027	0.00284	CcSEcCtD
Nitroglycerin—Vertigo—Triamcinolone—psoriatic arthritis	0.00267	0.00281	CcSEcCtD
Nitroglycerin—Syncope—Triamcinolone—psoriatic arthritis	0.00267	0.00281	CcSEcCtD
Nitroglycerin—Vertigo—Methylprednisolone—psoriatic arthritis	0.00266	0.00281	CcSEcCtD
Nitroglycerin—Syncope—Methylprednisolone—psoriatic arthritis	0.00266	0.0028	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.00264	0.00278	CcSEcCtD
Nitroglycerin—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.00261	0.00275	CcSEcCtD
Nitroglycerin—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.00261	0.00275	CcSEcCtD
Nitroglycerin—Shock—Prednisolone—psoriatic arthritis	0.00259	0.00273	CcSEcCtD
Nitroglycerin—Tachycardia—Prednisolone—psoriatic arthritis	0.00257	0.00271	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00255	0.00269	CcSEcCtD
Nitroglycerin—Infestation NOS—Methotrexate—psoriatic arthritis	0.00251	0.00265	CcSEcCtD
Nitroglycerin—Infestation—Methotrexate—psoriatic arthritis	0.00251	0.00265	CcSEcCtD
Nitroglycerin—Drowsiness—Methotrexate—psoriatic arthritis	0.00251	0.00265	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00251	0.00264	CcSEcCtD
Nitroglycerin—Flushing—Prednisone—psoriatic arthritis	0.0025	0.00264	CcSEcCtD
Nitroglycerin—Angioedema—Dexamethasone—psoriatic arthritis	0.00246	0.0026	CcSEcCtD
Nitroglycerin—Angioedema—Betamethasone—psoriatic arthritis	0.00246	0.0026	CcSEcCtD
Nitroglycerin—Stomatitis—Methotrexate—psoriatic arthritis	0.00245	0.00258	CcSEcCtD
Nitroglycerin—Angiopathy—Prednisone—psoriatic arthritis	0.00245	0.00258	CcSEcCtD
Nitroglycerin—Confusional state—Methylprednisolone—psoriatic arthritis	0.00244	0.00257	CcSEcCtD
Nitroglycerin—Immune system disorder—Prednisone—psoriatic arthritis	0.00244	0.00257	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00243	0.00256	CcSEcCtD
Nitroglycerin—Vertigo—Dexamethasone—psoriatic arthritis	0.00242	0.00255	CcSEcCtD
Nitroglycerin—Vertigo—Betamethasone—psoriatic arthritis	0.00242	0.00255	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00242	0.00255	CcSEcCtD
Nitroglycerin—Syncope—Dexamethasone—psoriatic arthritis	0.00242	0.00255	CcSEcCtD
Nitroglycerin—Syncope—Betamethasone—psoriatic arthritis	0.00242	0.00255	CcSEcCtD
Nitroglycerin—Arrhythmia—Prednisone—psoriatic arthritis	0.00241	0.00254	CcSEcCtD
Nitroglycerin—Infection—Triamcinolone—psoriatic arthritis	0.00241	0.00254	CcSEcCtD
Nitroglycerin—Sweating—Methotrexate—psoriatic arthritis	0.00241	0.00254	CcSEcCtD
Nitroglycerin—Infection—Methylprednisolone—psoriatic arthritis	0.0024	0.00253	CcSEcCtD
Nitroglycerin—Shock—Triamcinolone—psoriatic arthritis	0.00239	0.00251	CcSEcCtD
Nitroglycerin—Shock—Methylprednisolone—psoriatic arthritis	0.00238	0.00251	CcSEcCtD
Nitroglycerin—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00237	0.0025	CcSEcCtD
Nitroglycerin—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00237	0.0025	CcSEcCtD
Nitroglycerin—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00237	0.0025	CcSEcCtD
Nitroglycerin—Paraesthesia—Prednisolone—psoriatic arthritis	0.00237	0.0025	CcSEcCtD
Nitroglycerin—Tachycardia—Triamcinolone—psoriatic arthritis	0.00237	0.00249	CcSEcCtD
Nitroglycerin—Mental disorder—Prednisone—psoriatic arthritis	0.00236	0.00249	CcSEcCtD
Nitroglycerin—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00236	0.00249	CcSEcCtD
Nitroglycerin—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00235	0.00248	CcSEcCtD
Nitroglycerin—Erythema—Prednisone—psoriatic arthritis	0.00235	0.00247	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00234	0.00247	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00234	0.00247	CcSEcCtD
Nitroglycerin—Hypotension—Methylprednisolone—psoriatic arthritis	0.00226	0.00238	CcSEcCtD
Nitroglycerin—Pharyngitis—Methotrexate—psoriatic arthritis	0.00224	0.00236	CcSEcCtD
Nitroglycerin—Vision blurred—Prednisone—psoriatic arthritis	0.00221	0.00233	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.0022	0.00232	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.0022	0.00232	CcSEcCtD
Nitroglycerin—Infection—Dexamethasone—psoriatic arthritis	0.00219	0.0023	CcSEcCtD
Nitroglycerin—Infection—Betamethasone—psoriatic arthritis	0.00219	0.0023	CcSEcCtD
Nitroglycerin—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00218	0.0023	CcSEcCtD
Nitroglycerin—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00217	0.00229	CcSEcCtD
Nitroglycerin—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00217	0.00229	CcSEcCtD
Nitroglycerin—Visual impairment—Methotrexate—psoriatic arthritis	0.00217	0.00229	CcSEcCtD
Nitroglycerin—Shock—Betamethasone—psoriatic arthritis	0.00217	0.00228	CcSEcCtD
Nitroglycerin—Shock—Dexamethasone—psoriatic arthritis	0.00217	0.00228	CcSEcCtD
Nitroglycerin—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00216	0.00228	CcSEcCtD
Nitroglycerin—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00216	0.00227	CcSEcCtD
Nitroglycerin—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00216	0.00227	CcSEcCtD
Nitroglycerin—Agitation—Prednisone—psoriatic arthritis	0.00216	0.00227	CcSEcCtD
Nitroglycerin—Tachycardia—Betamethasone—psoriatic arthritis	0.00215	0.00226	CcSEcCtD
Nitroglycerin—Tachycardia—Dexamethasone—psoriatic arthritis	0.00215	0.00226	CcSEcCtD
Nitroglycerin—Angioedema—Prednisone—psoriatic arthritis	0.00215	0.00226	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00213	0.00224	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00213	0.00224	CcSEcCtD
Nitroglycerin—Vertigo—Prednisone—psoriatic arthritis	0.00211	0.00222	CcSEcCtD
Nitroglycerin—Syncope—Prednisone—psoriatic arthritis	0.00211	0.00222	CcSEcCtD
Nitroglycerin—Urticaria—Prednisolone—psoriatic arthritis	0.0021	0.00221	CcSEcCtD
Nitroglycerin—Cardiac disorder—Methotrexate—psoriatic arthritis	0.00209	0.0022	CcSEcCtD
Nitroglycerin—Loss of consciousness—Prednisone—psoriatic arthritis	0.00206	0.00218	CcSEcCtD
Nitroglycerin—Hypotension—Betamethasone—psoriatic arthritis	0.00206	0.00217	CcSEcCtD
Nitroglycerin—Hypotension—Dexamethasone—psoriatic arthritis	0.00206	0.00217	CcSEcCtD
Nitroglycerin—Angiopathy—Methotrexate—psoriatic arthritis	0.00205	0.00216	CcSEcCtD
Nitroglycerin—Immune system disorder—Methotrexate—psoriatic arthritis	0.00204	0.00215	CcSEcCtD
Nitroglycerin—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.00203	0.00214	CcSEcCtD
Nitroglycerin—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.002	0.00211	CcSEcCtD
Nitroglycerin—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00199	0.0021	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00199	0.00209	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00198	0.00209	CcSEcCtD
Nitroglycerin—Paraesthesia—Betamethasone—psoriatic arthritis	0.00198	0.00208	CcSEcCtD
Nitroglycerin—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00198	0.00208	CcSEcCtD
Nitroglycerin—Mental disorder—Methotrexate—psoriatic arthritis	0.00198	0.00208	CcSEcCtD
Nitroglycerin—Erythema—Methotrexate—psoriatic arthritis	0.00196	0.00207	CcSEcCtD
Nitroglycerin—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00194	0.00205	CcSEcCtD
Nitroglycerin—Urticaria—Triamcinolone—psoriatic arthritis	0.00193	0.00203	CcSEcCtD
Nitroglycerin—Urticaria—Methylprednisolone—psoriatic arthritis	0.00192	0.00203	CcSEcCtD
Nitroglycerin—Body temperature increased—Triamcinolone—psoriatic arthritis	0.00192	0.00202	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Prednisone—psoriatic arthritis	0.00192	0.00202	CcSEcCtD
Nitroglycerin—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00191	0.00202	CcSEcCtD
Nitroglycerin—Infection—Prednisone—psoriatic arthritis	0.0019	0.00201	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.0019	0.002	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.0019	0.002	CcSEcCtD
Nitroglycerin—Shock—Prednisone—psoriatic arthritis	0.00189	0.00199	CcSEcCtD
Nitroglycerin—Nervous system disorder—Prednisone—psoriatic arthritis	0.00188	0.00198	CcSEcCtD
Nitroglycerin—Tachycardia—Prednisone—psoriatic arthritis	0.00187	0.00197	CcSEcCtD
Nitroglycerin—Skin disorder—Prednisone—psoriatic arthritis	0.00186	0.00196	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Prednisone—psoriatic arthritis	0.00185	0.00195	CcSEcCtD
Nitroglycerin—Vision blurred—Methotrexate—psoriatic arthritis	0.00185	0.00195	CcSEcCtD
Nitroglycerin—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00181	0.00191	CcSEcCtD
Nitroglycerin—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00181	0.00191	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.0018	0.0019	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.0018	0.0019	CcSEcCtD
Nitroglycerin—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00179	0.00188	CcSEcCtD
Nitroglycerin—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00178	0.00188	CcSEcCtD
Nitroglycerin—Vertigo—Methotrexate—psoriatic arthritis	0.00176	0.00186	CcSEcCtD
Nitroglycerin—Urticaria—Dexamethasone—psoriatic arthritis	0.00175	0.00184	CcSEcCtD
Nitroglycerin—Urticaria—Betamethasone—psoriatic arthritis	0.00175	0.00184	CcSEcCtD
Nitroglycerin—Dizziness—Prednisolone—psoriatic arthritis	0.00174	0.00184	CcSEcCtD
Nitroglycerin—Asthenia—Triamcinolone—psoriatic arthritis	0.00174	0.00183	CcSEcCtD
Nitroglycerin—Body temperature increased—Betamethasone—psoriatic arthritis	0.00174	0.00183	CcSEcCtD
Nitroglycerin—Abdominal pain—Betamethasone—psoriatic arthritis	0.00174	0.00183	CcSEcCtD
Nitroglycerin—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00174	0.00183	CcSEcCtD
Nitroglycerin—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00174	0.00183	CcSEcCtD
Nitroglycerin—Asthenia—Methylprednisolone—psoriatic arthritis	0.00174	0.00183	CcSEcCtD
Nitroglycerin—Paraesthesia—Prednisone—psoriatic arthritis	0.00172	0.00181	CcSEcCtD
Nitroglycerin—Pruritus—Triamcinolone—psoriatic arthritis	0.00172	0.00181	CcSEcCtD
Nitroglycerin—Pruritus—Methylprednisolone—psoriatic arthritis	0.00171	0.0018	CcSEcCtD
Nitroglycerin—Rash—Prednisolone—psoriatic arthritis	0.00166	0.00175	CcSEcCtD
Nitroglycerin—Dermatitis—Prednisolone—psoriatic arthritis	0.00166	0.00175	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.00166	0.00175	CcSEcCtD
Nitroglycerin—Headache—Prednisolone—psoriatic arthritis	0.00165	0.00174	CcSEcCtD
Nitroglycerin—Confusional state—Methotrexate—psoriatic arthritis	0.00161	0.0017	CcSEcCtD
Nitroglycerin—Dizziness—Triamcinolone—psoriatic arthritis	0.0016	0.00169	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.0016	0.00169	CcSEcCtD
Nitroglycerin—Dizziness—Methylprednisolone—psoriatic arthritis	0.0016	0.00169	CcSEcCtD
Nitroglycerin—Infection—Methotrexate—psoriatic arthritis	0.00159	0.00168	CcSEcCtD
Nitroglycerin—Feeling abnormal—Prednisone—psoriatic arthritis	0.00158	0.00166	CcSEcCtD
Nitroglycerin—Asthenia—Dexamethasone—psoriatic arthritis	0.00158	0.00166	CcSEcCtD
Nitroglycerin—Asthenia—Betamethasone—psoriatic arthritis	0.00158	0.00166	CcSEcCtD
Nitroglycerin—Nervous system disorder—Methotrexate—psoriatic arthritis	0.00157	0.00166	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.00157	0.00165	CcSEcCtD
Nitroglycerin—Nausea—Prednisolone—psoriatic arthritis	0.00157	0.00165	CcSEcCtD
Nitroglycerin—Pruritus—Dexamethasone—psoriatic arthritis	0.00156	0.00164	CcSEcCtD
Nitroglycerin—Pruritus—Betamethasone—psoriatic arthritis	0.00156	0.00164	CcSEcCtD
Nitroglycerin—Skin disorder—Methotrexate—psoriatic arthritis	0.00156	0.00164	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.00155	0.00163	CcSEcCtD
Nitroglycerin—Vomiting—Triamcinolone—psoriatic arthritis	0.00154	0.00163	CcSEcCtD
Nitroglycerin—Vomiting—Methylprednisolone—psoriatic arthritis	0.00154	0.00162	CcSEcCtD
Nitroglycerin—Rash—Triamcinolone—psoriatic arthritis	0.00153	0.00161	CcSEcCtD
Nitroglycerin—Dermatitis—Triamcinolone—psoriatic arthritis	0.00153	0.00161	CcSEcCtD
Nitroglycerin—Rash—Methylprednisolone—psoriatic arthritis	0.00153	0.00161	CcSEcCtD
Nitroglycerin—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00152	0.00161	CcSEcCtD
Nitroglycerin—Urticaria—Prednisone—psoriatic arthritis	0.00152	0.0016	CcSEcCtD
Nitroglycerin—Headache—Triamcinolone—psoriatic arthritis	0.00152	0.0016	CcSEcCtD
Nitroglycerin—Headache—Methylprednisolone—psoriatic arthritis	0.00152	0.0016	CcSEcCtD
Nitroglycerin—Abdominal pain—Prednisone—psoriatic arthritis	0.00152	0.0016	CcSEcCtD
Nitroglycerin—Body temperature increased—Prednisone—psoriatic arthritis	0.00152	0.0016	CcSEcCtD
Nitroglycerin—Hypotension—Methotrexate—psoriatic arthritis	0.0015	0.00158	CcSEcCtD
Nitroglycerin—Dizziness—Dexamethasone—psoriatic arthritis	0.00146	0.00153	CcSEcCtD
Nitroglycerin—Dizziness—Betamethasone—psoriatic arthritis	0.00146	0.00153	CcSEcCtD
Nitroglycerin—Nausea—Triamcinolone—psoriatic arthritis	0.00144	0.00152	CcSEcCtD
Nitroglycerin—Paraesthesia—Methotrexate—psoriatic arthritis	0.00144	0.00152	CcSEcCtD
Nitroglycerin—Nausea—Methylprednisolone—psoriatic arthritis	0.00144	0.00151	CcSEcCtD
Nitroglycerin—Dyspnoea—Methotrexate—psoriatic arthritis	0.00143	0.0015	CcSEcCtD
Nitroglycerin—Somnolence—Methotrexate—psoriatic arthritis	0.00142	0.0015	CcSEcCtD
Nitroglycerin—Hypersensitivity—Prednisone—psoriatic arthritis	0.00141	0.00149	CcSEcCtD
Nitroglycerin—Vomiting—Betamethasone—psoriatic arthritis	0.0014	0.00147	CcSEcCtD
Nitroglycerin—Vomiting—Dexamethasone—psoriatic arthritis	0.0014	0.00147	CcSEcCtD
Nitroglycerin—Rash—Dexamethasone—psoriatic arthritis	0.00139	0.00146	CcSEcCtD
Nitroglycerin—Rash—Betamethasone—psoriatic arthritis	0.00139	0.00146	CcSEcCtD
Nitroglycerin—Dermatitis—Dexamethasone—psoriatic arthritis	0.00139	0.00146	CcSEcCtD
Nitroglycerin—Dermatitis—Betamethasone—psoriatic arthritis	0.00139	0.00146	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.00138	0.00146	CcSEcCtD
Nitroglycerin—Headache—Dexamethasone—psoriatic arthritis	0.00138	0.00145	CcSEcCtD
Nitroglycerin—Headache—Betamethasone—psoriatic arthritis	0.00138	0.00145	CcSEcCtD
Nitroglycerin—Asthenia—Prednisone—psoriatic arthritis	0.00138	0.00145	CcSEcCtD
Nitroglycerin—Pruritus—Prednisone—psoriatic arthritis	0.00136	0.00143	CcSEcCtD
Nitroglycerin—Feeling abnormal—Methotrexate—psoriatic arthritis	0.00132	0.00139	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.00131	0.00138	CcSEcCtD
Nitroglycerin—Nausea—Betamethasone—psoriatic arthritis	0.00131	0.00138	CcSEcCtD
Nitroglycerin—Nausea—Dexamethasone—psoriatic arthritis	0.00131	0.00138	CcSEcCtD
Nitroglycerin—Urticaria—Methotrexate—psoriatic arthritis	0.00127	0.00134	CcSEcCtD
Nitroglycerin—Dizziness—Prednisone—psoriatic arthritis	0.00127	0.00134	CcSEcCtD
Nitroglycerin—Abdominal pain—Methotrexate—psoriatic arthritis	0.00127	0.00133	CcSEcCtD
Nitroglycerin—Body temperature increased—Methotrexate—psoriatic arthritis	0.00127	0.00133	CcSEcCtD
Nitroglycerin—Vomiting—Prednisone—psoriatic arthritis	0.00122	0.00128	CcSEcCtD
Nitroglycerin—Rash—Prednisone—psoriatic arthritis	0.00121	0.00127	CcSEcCtD
Nitroglycerin—Dermatitis—Prednisone—psoriatic arthritis	0.00121	0.00127	CcSEcCtD
Nitroglycerin—Headache—Prednisone—psoriatic arthritis	0.0012	0.00127	CcSEcCtD
Nitroglycerin—Hypersensitivity—Methotrexate—psoriatic arthritis	0.00118	0.00124	CcSEcCtD
Nitroglycerin—Asthenia—Methotrexate—psoriatic arthritis	0.00115	0.00121	CcSEcCtD
Nitroglycerin—Nausea—Prednisone—psoriatic arthritis	0.00114	0.0012	CcSEcCtD
Nitroglycerin—Pruritus—Methotrexate—psoriatic arthritis	0.00113	0.00119	CcSEcCtD
Nitroglycerin—Dizziness—Methotrexate—psoriatic arthritis	0.00106	0.00112	CcSEcCtD
Nitroglycerin—Vomiting—Methotrexate—psoriatic arthritis	0.00102	0.00107	CcSEcCtD
Nitroglycerin—Rash—Methotrexate—psoriatic arthritis	0.00101	0.00106	CcSEcCtD
Nitroglycerin—Dermatitis—Methotrexate—psoriatic arthritis	0.00101	0.00106	CcSEcCtD
Nitroglycerin—Headache—Methotrexate—psoriatic arthritis	0.001	0.00106	CcSEcCtD
Nitroglycerin—Nausea—Methotrexate—psoriatic arthritis	0.000951	0.001	CcSEcCtD
